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Achieving and maintaining a desired body mass index 
(BMI) is one of the most challenging dimensions in the 
prevention and treatment of chronic disease. Obesity is 
a multifactorial condition and not only caused by the 
over-consumption of refined carbohydrates, but by the 
complex interaction of biological (metabolism, genetics, 
appetite), social, economic, environmental (work, stress, 
time, travelling) and psychological factors (self-perceptions, 
mood, emotions and motivation).
To combat obesity, most health organisations recommend 
embarking on an intensive lifestyle intervention using 
structured patient education and monitoring programmes. 
These require time and effort and it is understandable that some 
health professionals offer extreme macronutrient manipulation 
as an easier solution. High-protein saturated-fat diets have 
been widely recommended for the past 60 years as they 
seem to be effective for certain highly motivated individuals. 
Media attention, diet novelty and doctor enthusiasm can 
contribute to patient adherence to any type of diet. However, 
the question is whether following a diet that emphasises a 
specific macronutrient composition has any advantage towards 
the treatment of obesity? Diet adherence and behaviour 
modification (changing of eating habits) are considered as 
important, if not more so, than the macronutrient composition 
of the diet itself to long-term success.1-3
Weight loss
The efficacy of diets advocating extreme macronutrient 
manipulation has been reviewed extensively. Studies involving 
participation for 12 months or longer revealed that diet 
adherence, length of intervention and level of calorie 
ISSUES IN MEDICINE
Achieving weight loss and 
avoiding obesity
Maria Elizabeth Catsicas
The effect of the vast variety of nutrients on metabolic 
outcome and health is complex. A large number of factors 
play a role in the type and quantity of food consumed 
in free-living conditions. It is therefore obvious that 
prescribing a restrictive diet regimen that favours 1 or 
2 nutrients at the expense of the others is a poor tool to 
manage long-term health and weight. 
S Afr Med J 2012;102(9):730-732. DOI:10.7196/SAMJ.6054
Maria Elizabeth Catsicas is a registered dietician from Nutritional 
Solutions in Johannesburg.
Corresponding author: M E Catsicas (ria@nutritionalsolutions.co.za)
731  September 2012, Vol. 102, No. 9  SAMJ
restriction were far more important than adherence to a very low-
carbohydrate regimen. Although obese patients following high-
protein low-carbohydrate diets show greater weight loss in the first 
6 months, weight-loss differences between diets at 12 months tend 
to be insignificant. All patients, whether following high- or low-
carbohydrate or high- or low-protein and fat diets, transcend to a 
moderate intake of all macronutrients at the end of 12 months. This is 
a clear indication that food variety, individual lifestyle constraints and 
social and cultural aspects need to be addressed when recommending 
weight-loss strategies.4-8 
The importance of fats
Numerous factors apart from low-density lipoprotein (LDL)-
cholesterol contribute to cardiovascular disease (CVD). The 
sub-types of dietary fats, proteins and carbohydrates, and levels of 
consumption, affect blood fats differently (including triglycerides 
(TGs), total cholesterol (TC)/high-density lipoprotein (HDL)-
cholesterol ratio, LDL-C particle size). Additional factors 
contributing to risk, in unique ways, include inflammation, weight 
status, endothelial dysfunction and hypertension.
The South African Heart Association and the Lipid and 
Atherosclerosis Society of Southern Africa (LASSA) have 
adopted the European Society of Cardiology (ESC)/European 
Atherosclerosis Society recommendation that the appropriate 
strategy to lower LDL-C is to replace saturated and trans-fatty 
acids (hydrogenated fats) with unsaturated fatty acids. Not only 
carbohydrates, but the type and quantity of fats have the following 
effects: 
•	 Saturated fatty acids raise TC, LDL-C and HDL-C depending on 
the cholesterol and unsaturated fat content of the diet
•	 Trans-fatty acids raise TC and LDL-C, lower HDL-C, have pro-
inflammatory effects and contribute to endothelial dysfunction
•	 Poly- and mono-unsaturated fatty acids lower TC, LDL-C and 
TG, without lowering HDL-C. 
The substitution of saturated and trans-fats with unsaturated 
fats rather than carbohydrates is recommended as this contributes 
to a reduction in small dense LDL-C. Lower-fat and consequently 
higher-carbohydrate diets raise TG and reduce HDL-C. This is 
especially important for overweight and obese patients with an 
atherogenic profile typical of the metabolic syndrome or type 2 
diabetes. Although poly- and mono-unsaturated fats have equal 
effects, the latter have anti-inflammatory properties, and the former 
may increase susceptibility of LDL-C to oxidation.
The ESC recommends that saturated and trans-fats should not 
exceed 10% and 1% of total energy intake, respectively. Poly-
unsaturated fatty acids should be limited to 10% of energy intake to 
minimise the risk of lipoprotein peroxidation and HDL-C decrease. 
A diet of low to moderate fat (30 - 35% total energy), moderate 
carbohydrates (40 - 45%) and moderate protein (15 - 20%), can 
thus be beneficial in lowering TGs and raising HDL-C without 
exacerbating weight or glycaemic control.9-13 
The importance of carbohydrates
Weight loss has been shown to improve the atherogenic dyslipidaemia 
and insulin resistance that occurs concomitantly with abdominal 
adiposity. This has been achieved with different levels of carbohydrate 
intake; therefore, it is critical to evaluate the necessity of consuming a 
very low-carbohydrate ketogenic diet to achieve optimal metabolism. 
The American Diabetes Association (ADA) designates low- to 
moderate-carbohydrate diets as 130 g or 26 - 45% of calorie intake 
per day (2 000 kcal), and very low ketogenic diets as 30 g or 6% of 
calorie intake per day.
Low-carbohydrate diets can lead to weight and metabolic 
improvements in the short term (<1 year).14-16 However, they offer no 
additional benefits to blood-lipid changes independent of weight loss. 
Ketogenic and moderate-carbohydrate diets offer equal benefits to 
weight loss and insulin resistance. However, the use of ketogenic diets 
is not warranted as they can have adverse metabolic effects and alter 
energy levels and mood. Reported ketogenic diet side-effects include 
headaches, constipation and lack of concentration.17-20
Carbohydrate type and quantity contribute more or less equally 
to the post-prandial glycaemic response. There has always been 
consensus on the adverse metabolic effects of free sugar and refined 
carbohydrate over-consumption. However, none of these effects have 
been observed in the consumption of fresh fruit and vegetables or 
whole grains. A ketogenic diet does not allow for the adequate intake 
of these foods, and therefore lacks sufficient provision of fibre, anti-
oxidants, phytochemicals, vitamins and minerals (especially folic 
acid, magnesium, vitamin E and potassium), all of which are of vital 
to protection against chronic disease.21-23
The importance of protein
Recent studies have shown that the effects of saturated fats on 
atherogenic lipoproteins may be dependent on protein source and 
dietary context. Furthermore, findings suggest all processed meats 
high in saturated fat, sodium, nitrates and phosphates have adverse 
effects. It has therefore been recommended that processed meats 
should be avoided, red meat should be limited, and protein from fish 
and plant sources should be increased.. 
A meta-analysis of 27 randomised observational trials showed 
the beneficial effects of a plant-based diet on plasma lipids. TC and 
LDL-C reductions of approximately 17% and 10 - 15% have been 
observed with pure vegan and ovo-lacto/semi-vegetarian diets, 
respectively.25 Nuts contain several bioactive substances such as 
unsaturated fats, proteins (L-arginine, a nitric oxide precursor), 
fibre, folic acid, minerals, anti-oxidants and phytochemicals with 
proven benefit to cardiovascular health. Furthermore, long-term 
studies have shown that regular fish consumption can lower 
cardiovascular event rates. The American Heart Association (AHA) 
recommends a daily intake of 250 mg of C20:5 n-3 eicosapentaenoic 
acid (EPA) and C22:6 n-3 docosahexaenoic acid (DHA), derived 
from 2 - 3 portions of fatty fish per week. Compared with no 
fish consumption, this amount of fatty acids is associated with 
a 36% lower coronary heart disease (CHD) mortality. Essential 
fatty acids have additional benefits in reducing inflammation, 
improving endothelial function, promoting myocardial relaxation 
and normalising heart rate variability.26,27
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